PIVLAZ Trademark

Trademark Overview


On Friday, October 12, 2018, a trademark application was filed for PIVLAZ with the United States Patent and Trademark Office. The USPTO has given the PIVLAZ trademark a serial number of 79245536. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2019. This trademark is owned by Idorsia Pharmaceuticals Ltd.. The PIVLAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for cardiovascular, pulmonary, inflammatory indications, for the treatment of pathological incidents of the central nervous system, in particular subarachnoid hemorrhage and sequelae thereof, as well as for the treatment of cancer
pivlaz

General Information


Serial Number79245536
Word MarkPIVLAZ
Filing DateFriday, October 12, 2018
Status700 - REGISTERED
Status DateTuesday, November 26, 2019
Registration Number5917208
Registration DateTuesday, November 26, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for cardiovascular, pulmonary, inflammatory indications, for the treatment of pathological incidents of the central nervous system, in particular subarachnoid hemorrhage and sequelae thereof, as well as for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIdorsia Pharmaceuticals Ltd.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressCH

Party NameIdorsia Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressCH

Party NameIdorsia Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressCH

Trademark Events


Event DateEvent Description
Friday, April 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, March 15, 2020FINAL DISPOSITION NOTICE SENT TO IB
Saturday, March 14, 2020FINAL DISPOSITION PROCESSED
Wednesday, February 26, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 8, 2019ASSIGNED TO LIE
Monday, July 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 1, 2019REFUSAL PROCESSED BY IB
Wednesday, February 6, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 6, 2019REFUSAL PROCESSED BY MPU
Thursday, January 24, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 23, 2019NON-FINAL ACTION WRITTEN
Wednesday, January 23, 2019ASSIGNED TO EXAMINER
Friday, November 23, 2018APPLICATION FILING RECEIPT MAILED
Monday, November 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 15, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB